第一資本信貸 COF 深 滬
已收盤 01-09 16:00:00 美东时间
249.20
-6.480
-2.53%
華盛通- 最 高256.51
- 今 開256.00
- 成交量 383.43万股
- 最 低 249.09
- 昨 收 255.68
- 總市值 1584.91亿
- 52周最高 259.635
- 市盈率 靜 21.51
- 換手率 0.60%
- 52周最低 141.22
- 委 比 33.33%
- 總股本 6.36亿
- 歷史最高 259.635
- 量 比 0.99
- 振 幅 2.90%
- 歷史最低 14.14
- 每 手 1
- 風險率 22.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Trump calls for a 10% cap on credit card interest rates for a year
President Donald Trump late Friday called for a one-year cap on credit card interest rates at 10%, effective Jan. 20, noting that he will not allow Americans to be “ripped off” by credit card firms wh...
01-10 21:10
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
TD Cowen Maintains Buy on Capital One Finl, Raises Price Target to $290
TD Cowen analyst Moshe Orenbuch maintains Capital One Finl (NYSE:COF) with a Buy and raises the price target from $261 to $290.
01-09 01:48
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
美股大行评级 | 杰富瑞上调百度目标价从159美元升至181美元；花旗下调京东目标价从44美元下调至37美元
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从47美元升至48美元；BTIG：维持Hudson Pacific Properties"买入"评级，目标价从4.75美元升至26美元
01-05 13:52
BTIG’s 2026 top picks report spotlights 21 large-cap stocks to watch
BTIG’s Top Picks report brings together the firm’s highest-conviction investment ideas drawn from its research platform, with a 12-month investment horizon beginning in the first half of 2026. As the ...
01-02 21:21
美股大行评级 | 潜在涨幅108.88%！TeraWulf获Keefe, Bruyette & Woods上调目标价至24美元，评级升至"跑赢大市"
今日重点评级关注：Keefe, Bruyette & Woods：上调TeraWulf Inc Ordinary Shares评级至"跑赢大市"，目标价从9.5美元升至24美元；B. Riley证券：维持万达生物制药"买入"评级，目标价从11美元升至14美元
01-02 15:10
Here's How Much You Would Have Made Owning Capital One Finl Stock In The Last 5 Years
Capital One Finl (NYSE:COF) has outperformed the market over the past 5 years b...
01-02 00:15
A 2025 M&A revival has bankers eager for more
Mergers & acquisition activity recovered and then some in 2025, as the number of deals valued at $10B or more hit a new high. For the year, so far, there were a record 68 deals each valued at over $10...
01-01 00:41
